The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 309

Multimodal Evoked Potentials and Magnetic Resonance Imaging in Wilson's disease

F. GÖKÇAY, N. ÇELEBİSOY, A. GÖKÇAY, H. KARASOY, Ö. AKYÜREKLİ, A. ÜLKÜ

Issue: 1999, Volume 5 - Issue 1
0 300

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 306

The New MRI Tecniques In Acute Cerebral Ischemia

Hale ERSOY, Cüneyt AYTEKİN, A. Muhteşem AĞILDERE, Sibel BENLİ, Ufuk CAN

Issue: 1998, Volume 4 - Issue 3-4
0 368

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 356

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 513

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 304

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 305

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 453

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 539

Post COVID-19 Rhino-Orbital-Cerebral Mucormycosis: The Guitar Pick Sign

Kiran Kumar Ramineni, Krishna Mohan Reddy Gangireddy, Sashidhar Reddy Gutha, Ravi Kanth Jakkani, Ugandhar Bhattu

DOI: 10.4274/tnd.2021.35493

Issue: 2021, Volume 27 - Supplement 1
0 463

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 439

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 480

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 375

Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports

Murat TERZİ

Issue: 2009, Volume 15 - Supplement 3
0 551

The influence of self-care agency on quality of life in patients with multiple sclerosis

Ahsen Taştan Gürkan, Afitap Özdelikara

DOI: 10.55697/tnd.2024.9

Issue: 2024, Volume 30 - Issue 3
1026 610

Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning

İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi

DOI: 10.55697/tnd.2024.107

Issue: 2024, Volume 30 - Issue 3
984 493

The relationship between lesion volume, oligoclonal bands, and cerebrospinal fluid/serum albumin ratio in multiple sclerosis

Güllü Tarhan, Burçe Akbağra Kaya, Arif Musab Akıner, Yaren Betül Yılmaz, Saime Füsun Domaç

DOI: 10.55697/tnd.2024.88

Issue: 2024, Volume 30 - Issue 4
615 649

Picture of multiple sclerosis studies in nursing: A bibliometric study

Esra Uslu, Nazmiye Yıldırım

DOI: 10.55697/tnd.2024.15

Issue: 2024, Volume 30 - Issue 4
635 543

The effect of demographic features and environmental risk factors on the clinical course in patients with multiple sclerosis

İrem İlgezdi Kaya, Bedile İrem Tiftikçioğlu, Yaşar Zorlu, Levent Öcek, Ufuk Şener, Figen Tokuçoğlu

DOI: 10.55697/tnd.2025.211

Issue: 2025, Volume 31 - Issue 2
170 123